▶ 調査レポート

ハンチントン病治療の世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Huntington’s Disease Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。ハンチントン病治療の世界市場 2020年:企業別、地域別、種類・用途別 / Global Huntington’s Disease Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D005-00497資料のイメージです。• レポートコード:D005-00497
• 出版社/出版日:GlobalInfoResearch / 2020年5月29日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ハンチントン病治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ハンチントン病治療の種類別市場規模(対症療法、疾患修飾療法)、用途別市場規模(病院、外来手術センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Bausch Health、Ionis Pharmaceuticals/ Roche、Teva Pharmaceuticals、Wave Life Sciences、Prana Biotechnology、Raptor Pharmaceuticals
・地域別グローバル市場分析 2015年-2020年
・ハンチントン病治療の北米市場(アメリカ、カナダ、メキシコ)
・ハンチントン病治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ハンチントン病治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ハンチントン病治療の南米市場(ブラジル、アルゼンチン)
・ハンチントン病治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:対症療法、疾患修飾療法
・用途別分析:病院、外来手術センター
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Huntington’s Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 29.6% in the forecast period of 2020 to 2025 and will expected to reach USD 509 million by 2025, from USD 180.4 million in 2019.

The Huntington’s Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Huntington’s Disease Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Huntington’s Disease Treatment market has been segmented into:
Symptomatic Therapy
Disease-Modifying Therapy

By Application, Huntington’s Disease Treatment has been segmented into:
Hospitals
Ambulatory Surgical Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Huntington’s Disease Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Huntington’s Disease Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Huntington’s Disease Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Huntington’s Disease Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Huntington’s Disease Treatment Market Share Analysis
Huntington’s Disease Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Huntington’s Disease Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Huntington’s Disease Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Huntington’s Disease Treatment are:
Bausch Health
Ionis Pharmaceuticals/ Roche
Teva Pharmaceuticals
Wave Life Sciences
Prana Biotechnology
Raptor Pharmaceuticals

レポート目次

Table of Contents

1 Huntington’s Disease Treatment Market Overview
1.1 Product Overview and Scope of Huntington’s Disease Treatment
1.2 Classification of Huntington’s Disease Treatment by Type
1.2.1 Global Huntington’s Disease Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Huntington’s Disease Treatment Revenue Market Share by Type in 2019
1.2.3 Symptomatic Therapy
1.2.4 Disease-Modifying Therapy
1.3 Global Huntington’s Disease Treatment Market by Application
1.3.1 Overview: Global Huntington’s Disease Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Global Huntington’s Disease Treatment Market by Regions
1.4.1 Global Huntington’s Disease Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Huntington’s Disease Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Huntington’s Disease Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Huntington’s Disease Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Huntington’s Disease Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Huntington’s Disease Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Huntington’s Disease Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bausch Health
2.1.1 Bausch Health Details
2.1.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bausch Health SWOT Analysis
2.1.4 Bausch Health Product and Services
2.1.5 Bausch Health Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ionis Pharmaceuticals/ Roche
2.2.1 Ionis Pharmaceuticals/ Roche Details
2.2.2 Ionis Pharmaceuticals/ Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ionis Pharmaceuticals/ Roche SWOT Analysis
2.2.4 Ionis Pharmaceuticals/ Roche Product and Services
2.2.5 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva Pharmaceuticals
2.3.1 Teva Pharmaceuticals Details
2.3.2 Teva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Teva Pharmaceuticals SWOT Analysis
2.3.4 Teva Pharmaceuticals Product and Services
2.3.5 Teva Pharmaceuticals Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Wave Life Sciences
2.4.1 Wave Life Sciences Details
2.4.2 Wave Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Wave Life Sciences SWOT Analysis
2.4.4 Wave Life Sciences Product and Services
2.4.5 Wave Life Sciences Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Prana Biotechnology
2.5.1 Prana Biotechnology Details
2.5.2 Prana Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Prana Biotechnology SWOT Analysis
2.5.4 Prana Biotechnology Product and Services
2.5.5 Prana Biotechnology Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Raptor Pharmaceuticals
2.6.1 Raptor Pharmaceuticals Details
2.6.2 Raptor Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Raptor Pharmaceuticals SWOT Analysis
2.6.4 Raptor Pharmaceuticals Product and Services
2.6.5 Raptor Pharmaceuticals Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Huntington’s Disease Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Huntington’s Disease Treatment Players Market Share
3.2.2 Top 10 Huntington’s Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Huntington’s Disease Treatment Revenue and Market Share by Regions
4.2 North America Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
5 North America Huntington’s Disease Treatment Revenue by Countries
5.1 North America Huntington’s Disease Treatment Revenue by Countries (2015-2020)
5.2 USA Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
6 Europe Huntington’s Disease Treatment Revenue by Countries
6.1 Europe Huntington’s Disease Treatment Revenue by Countries (2015-2020)
6.2 Germany Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
6.4 France Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Huntington’s Disease Treatment Revenue by Countries
7.1 Asia-Pacific Huntington’s Disease Treatment Revenue by Countries (2015-2020)
7.2 China Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
7.5 India Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
8 South America Huntington’s Disease Treatment Revenue by Countries
8.1 South America Huntington’s Disease Treatment Revenue by Countries (2015-2020)
8.2 Brazil Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Huntington’s Disease Treatment by Countries
9.1 Middle East & Africa Huntington’s Disease Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Huntington’s Disease Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Huntington’s Disease Treatment Market Forecast by Type (2019-2024)
10.3 Symptomatic Therapy Revenue Growth Rate (2015-2025)
10.4 Disease-Modifying Therapy Revenue Growth Rate (2015-2025)
11 Global Huntington’s Disease Treatment Market Segment by Application
11.1 Global Huntington’s Disease Treatment Revenue Market Share by Application (2015-2020)
11.2 Huntington’s Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Huntington’s Disease Treatment Market Size Forecast (2021-2025)
12.1 Global Huntington’s Disease Treatment Market Size Forecast (2021-2025)
12.2 Global Huntington’s Disease Treatment Market Forecast by Regions (2021-2025)
12.3 North America Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
12.6 South America Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Huntington’s Disease Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Huntington’s Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Huntington’s Disease Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Huntington’s Disease Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bausch Health Corporate Information, Location and Competitors
Table 6. Bausch Health Huntington’s Disease Treatment Major Business
Table 7. Bausch Health Huntington’s Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Bausch Health SWOT Analysis
Table 9. Bausch Health Huntington’s Disease Treatment Product and Solutions
Table 10. Bausch Health Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Ionis Pharmaceuticals/ Roche Corporate Information, Location and Competitors
Table 12. Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Major Business
Table 13. Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Ionis Pharmaceuticals/ Roche SWOT Analysis
Table 15. Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Product and Solutions
Table 16. Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Teva Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Teva Pharmaceuticals Huntington’s Disease Treatment Major Business
Table 19. Teva Pharmaceuticals Huntington’s Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Teva Pharmaceuticals SWOT Analysis
Table 21. Teva Pharmaceuticals Huntington’s Disease Treatment Product and Solutions
Table 22. Teva Pharmaceuticals Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Wave Life Sciences Corporate Information, Location and Competitors
Table 24. Wave Life Sciences Huntington’s Disease Treatment Major Business
Table 25. Wave Life Sciences Huntington’s Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Wave Life Sciences SWOT Analysis
Table 27. Wave Life Sciences Huntington’s Disease Treatment Product and Solutions
Table 28. Wave Life Sciences Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Prana Biotechnology Corporate Information, Location and Competitors
Table 30. Prana Biotechnology Huntington’s Disease Treatment Major Business
Table 31. Prana Biotechnology Huntington’s Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Prana Biotechnology SWOT Analysis
Table 33. Prana Biotechnology Huntington’s Disease Treatment Product and Solutions
Table 34. Prana Biotechnology Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Raptor Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Raptor Pharmaceuticals Huntington’s Disease Treatment Major Business
Table 37. Raptor Pharmaceuticals Huntington’s Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Raptor Pharmaceuticals SWOT Analysis
Table 39. Raptor Pharmaceuticals Huntington’s Disease Treatment Product and Solutions
Table 40. Raptor Pharmaceuticals Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Huntington’s Disease Treatment Revenue (Million USD) by Players (2015-2020)
Table 42. Global Huntington’s Disease Treatment Revenue Share by Players (2015-2020)
Table 43. Global Huntington’s Disease Treatment Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Huntington’s Disease Treatment Revenue Market Share by Regions (2015-2020)
Table 45. North America Huntington’s Disease Treatment Revenue by Countries (2015-2020)
Table 46. North America Huntington’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 47. Europe Huntington’s Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Huntington’s Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Huntington’s Disease Treatment Revenue by Countries (2015-2020)
Table 50. South America Huntington’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Huntington’s Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Huntington’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Global Huntington’s Disease Treatment Revenue (Million USD) by Type (2015-2020)
Table 54. Global Huntington’s Disease Treatment Revenue Share by Type (2015-2020)
Table 55. Global Huntington’s Disease Treatment Revenue Forecast by Type (2021-2025)
Table 56. Global Huntington’s Disease Treatment Revenue by Application (2015-2020)
Table 57. Global Huntington’s Disease Treatment Revenue Share by Application (2015-2020)
Table 58. Global Huntington’s Disease Treatment Revenue Forecast by Application (2021-2025)
Table 59. Global Huntington’s Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Huntington’s Disease Treatment Picture
Figure 2. Global Huntington’s Disease Treatment Revenue Market Share by Type in 2019
Figure 3. Symptomatic Therapy Picture
Figure 4. Disease-Modifying Therapy Picture
Figure 5. Huntington’s Disease Treatment Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Global Huntington’s Disease Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Huntington’s Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Huntington’s Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Huntington’s Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Huntington’s Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Huntington’s Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Huntington’s Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Huntington’s Disease Treatment Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Huntington’s Disease Treatment Revenue Market Share in 2019
Figure 17. Global Top 10 Players Huntington’s Disease Treatment Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Huntington’s Disease Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Huntington’s Disease Treatment Revenue Market Share by Regions (2015-2020)
Figure 21. Global Huntington’s Disease Treatment Revenue Market Share by Regions in 2018
Figure 22. North America Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 23. Europe Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 25. South America Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 27. North America Huntington’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 28. North America Huntington’s Disease Treatment Revenue Market Share by Countries in 2019
Figure 29. USA Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Canada Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Europe Huntington’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Huntington’s Disease Treatment Revenue Market Share by Countries in 2019
Figure 34. Germany Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 35. UK Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 36. France Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Russia Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Italy Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Huntington’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Huntington’s Disease Treatment Revenue Market Share by Countries in 2019
Figure 41. China Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Japan Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Korea Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 44. India Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 46. South America Huntington’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 47. South America Huntington’s Disease Treatment Revenue Market Share by Countries in 2019
Figure 48. Brazil Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Huntington’s Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Huntington’s Disease Treatment Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 53. UAE Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Huntington’s Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Global Huntington’s Disease Treatment Revenue Share by Type (2015-2020)
Figure 57. Global Huntington’s Disease Treatment Revenue Share by Type in 2019
Figure 58. Global Huntington’s Disease Treatment Market Share Forecast by Type (2021-2025)
Figure 59. Global Symptomatic Therapy Revenue Growth Rate (2015-2020)
Figure 60. Global Disease-Modifying Therapy Revenue Growth Rate (2015-2020)
Figure 61. Global Huntington’s Disease Treatment Revenue Share by Application (2015-2020)
Figure 62. Global Huntington’s Disease Treatment Revenue Share by Application in 2019
Figure 63. Global Huntington’s Disease Treatment Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 65. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 66. Global Huntington’s Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Huntington’s Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Huntington’s Disease Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
Figure 70. Europe Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
Figure 72. South America Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Huntington’s Disease Treatment Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel